Steatotic liver disease among lean and non-lean individuals in Southern Lao PDR: a cross-sectional study of risk factors

被引:3
作者
Homsana, Anousin [1 ,2 ,3 ]
Southisavath, Phonesavanh [1 ,2 ,3 ,4 ]
Kling, Kerstin [5 ]
Hattendorf, Jan [2 ,3 ]
Vorasane, Savina [4 ]
Paris, Daniel Henry [2 ,3 ]
Sayasone, Somphou [1 ]
Odermatt, Peter [2 ,3 ]
Probst-Hensch, Nicole [2 ,3 ]
机构
[1] Minist Hlth, Lao Trop & Publ Hlth Inst, Vientiane Capital, Laos
[2] Swiss Trop & Publ Hlth Inst, CH-4123 Allschwil, Switzerland
[3] Univ Basel, Basel, Switzerland
[4] Minist Hlth, Dept Radiol, Mahosot Hosp, Vientiane Capital, Laos
[5] Robert Koch Inst, Immunizat Unit, Berlin, Germany
基金
瑞士国家科学基金会;
关键词
Lao PDR; steatotic liver disease; hepatic steatosis; metabolic dysfunction-associated steatotic liver disease; type 2 diabetes mellitus; metabolic diseases; opisthorchis viverrini; lipids; FATTY; DIAGNOSIS;
D O I
10.1080/07853890.2024.2329133
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Steatotic liver disease (SLD) prevalence is rising worldwide, linked to insulin resistance and obesity. SLD prevalence can surpass 10% even among those with normal weight. In Lao People's Democratic Republic (Lao PDR), where Opisthorchis viverrini (OV) trematode infection and type 2 diabetes mellitus (T2DM) are common, infection related liver morbidity such as cholangiocarcinoma (CCA) is high, but data on SLD prevalence is lacking. The objective of this study was to estimate the prevalence and explore determinants of SLD in rural southern Lao PDR for lean and non-lean populations. Method: A cross-sectional community-based study assessed SLD prevalence using abdominal ultrasonography (US). Factors investigated for association with SLD were identified by interview, serological tests (Hepatitis B surface antigen (HBsAg); lipids and HbA1c), anthropometrical measurements, and parasitological assessments (OV infection). Uni- and multivariable logistic regression analyses with SLD as endpoint were conducted separately for lean (body mass index (BMI) <23.0 kg/m(2)) and non-lean (BMI >= 23.0 kg/m(2)) participants. Result: 2,826 participants were included. SLD prevalence was 27.1% (95% confidence interval (95% CI) 24.0%-30.4%), higher among non-lean (39.8%) than lean individuals (17.4%). Lean individuals with OV infection had a statistically significant association with lower odds of SLD (adjusted odds ratio (aOR) 0.49, 95% CI 0.33 - 0.73). T2DM showed a significant positive association with SLD in both lean (aOR 3.58, 95% CI 2.28 - 5.63) and non-lean individuals (aOR 3.31, 95% CI 2.31 - 4.74) while dyslipidemia was significantly associated only in the non-lean group (aOR 1.83, 95% CI 1.09 - 3.07). Females participants exhibited elevated odds of SLD in both lean (aOR 1.43, 95% CI 1.02 - 2.01) and non-lean SLD (aOR 1.50, 95% CI 1.12 - 2.01). Conclusion: SLD prevalence is notably high among Laotian adults in rural areas, particularly in females and in non-lean individuals. Lean individuals with OV infection exhibited lower SLD prevalence. SLD was more prevalent in individuals with T2DM, independent of BMI. SLD adds to the burden of infection-related liver morbidity in Lao PDR.
引用
收藏
页数:16
相关论文
共 44 条
  • [1] The natural history of nonalcoholic fatty liver disease: A population-based cohort study
    Adams, LA
    Lymp, JF
    St Sauver, J
    Sanderson, SO
    Lindor, KD
    Feldstein, A
    Angulo, P
    [J]. GASTROENTEROLOGY, 2005, 129 (01) : 113 - 121
  • [2] Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
    Akhtar, Daud H.
    Iqbal, Umair
    Vazquez-Montesino, Luis Miguel
    Dennis, Brittany B.
    Ahmed, Aijaz
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (04) : 362 - 370
  • [3] Epidemiology and prevalence of lean nonalcoholic fatty liver disease and associated cirrhosis, hepatocellular carcinoma, and cardiovascular outcomes in the United States: a population-based study and review of literature
    Almomani, Ashraf
    Kumar, Prabhat
    Onwuzo, Somtochukwu
    Boustany, Antoine
    Krishtopaytis, Eduard
    Hitawala, Asif
    Alshaikh, Dana
    Albakri, Almaza
    Hussein, Leen
    Hussein, Ebrahim
    Asaad, Imad
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (02) : 269 - 273
  • [4] Opisthorchis viverrini: an underestimated parasite in world health
    Andrews, Ross H.
    Sithithaworn, Paiboon
    Petney, Trevor N.
    [J]. TRENDS IN PARASITOLOGY, 2008, 24 (11) : 497 - 501
  • [6] Opisthorchis viverrini Infection Augments the Severity of Nonalcoholic Fatty Liver Disease in High-Fat/High-Fructose Diet-Fed Hamsters
    Chaidee, Apisit
    Onsurathum, Sudarat
    Intuyod, Kitti
    Haonon, Ornuma
    Pannangpetch, Patchareewan
    Pongchaiyakul, Chatlert
    Pinlaor, Porntip
    Pairojkul, Chawalit
    Welbat, Jariya Umka
    Ittiprasert, Wannaporn
    Cochran, Christina J.
    Mann, Victoria H.
    Brindley, Paul J.
    Pinlaor, Somchai
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 (05) : 1161 - 1169
  • [7] The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
    Chalasani, Naga
    Younossi, Zobair
    Lavine, Joel E.
    Charlton, Michael
    Cusi, Kenneth
    Rinella, Mary
    Harrison, Stephen A.
    Brunt, Elizabeth M.
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 328 - 357
  • [8] Human Fatty Liver Disease: Old Questions and New Insights
    Cohen, Jonathan C.
    Horton, Jay D.
    Hobbs, Helen H.
    [J]. SCIENCE, 2011, 332 (6037) : 1519 - 1523
  • [9] Special Population Lean Nonalcoholic Fatty Liver Disease
    Duseja, Ajay
    De, Arka
    Wong, Vincent
    [J]. CLINICS IN LIVER DISEASE, 2023, 27 (02) : 451 - 469
  • [10] EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
    European Association for the Study of the Liver
    [J]. DIABETOLOGIA, 2016, 59 (06) : 1121 - 1140